For years, many providers stopped using hormone replacement therapy for menopause after a 2002 study showed there was a risk ...

U.S. Physical Therapy (USPH) shares have seen mixed movement lately. The stock rose 1% in the past day but is down 2% over the past month. Investors continue weighing the company’s financial ...

U.S. Physical Therapy recently prepared to release its third-quarter 2025 earnings report following a year shaped by significant clinic acquisitions and the industrial injury prevention segment ...

Qure (QURE) shares have taken a hit after the FDA withdrew support for using Phase I/II data from its AMT-130 Huntington's disease gene therapy in a key regulatory submission. This unexpected shift ...

Discover how the "Inner Courtroom" helps survivors of abuse reclaim power, voice, and meaning, turning trauma into healing ...

The excitement around Vertex’s kidney therapy news comes as share price momentum has started ... With shares closing at ...

I find myself fatigued from the news cycle lately, a precarious position to be in when I need to be writing about them every ...

Identifying bullying may seem like the job of schools, but therapists can help by learning to make it a compulsory assessment ...

Former 'Bachelorette' Katie Thurston and editor Paige Stables discuss the invisible side of a stage four diagnosis—and the ...

In the heart of Kansas City, Uzazi Village is rewriting the story of maternal health - one family, one birth, one community ...

Author Jay Watkins' research offers proof of Richmond's rich queer history, especially in the world of theatre.

While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.